Halozyme Therapeutics Inc. – Filings and Transcripts

NASDAQ: HALO
Share price (9/30/26): $110.40
Market cap (9/30/26): $12.5 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Third party tender offer – amended

Third party tender offer – amended

Third party tender offer – amended

Third party tender offer

Ownership Filter

Posard Matthew L.

Posard Matthew L.

Appelhans Dannielle

Appelhans Dannielle

News Filter

Change in Directors, Officers or Compensation

Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement, Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Announces Pricing of Upsized Private Offering of $1.3 Billion of Convertible Senior Notes Due 2033

Announces Proposed Offering of $1.05 Billion of Convertible Senior Notes Due 2033

Change in Directors, Officers or Compensation

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC